This episode was filmed at the 2026 Abundance360 Summit. Learn more at https://www.abundance360.com/ In this insightful interview, Dr. David Sinclair discusses groundbreaking advancements in longevity research, including epigenetic reprogramming trials, the potential for extending human lifespan, and accessible therapies. He shares his personal protocols and the future of anti-aging science, emphasizing the importance of innovation and community support. Get access to metatrends 10+ years before anyone else - https://qr.diamandis.com/metatrends David A. Sinclair, A.O., Ph.D., is a tenured Professor of Genetics at Harvard Medical School and a serial biotech entrepreneur. Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360 Chapters: 00:00 - The Dawn of Epigenetic Reprogramming 02:44 - Exploring the Potential of Longevity Therapeutics 05:26 - Innovations in Gene Therapy and Accessibility 07:56 - The Future of Longevity: Cost and Accessibility 10:44 - The Science of Aging: Limits and Possibilities 13:01 - Funding Science: A New Approach to Research 15:49 - Personal Longevity Protocols and Lifestyle Choices – My companies: Apply to Dave's and my new fund: https://qr.diamandis.com/linkventureslanding Go to Blitzy to book a free demo and start building today: https://qr.diamandis.com/blitzy Your body is incredibly good at hiding disease. Schedule a call with Fountain Life to add healthy decades to your life, and to learn more about their Memberships: https://www.fountainlife.com/peter _ Connect with Peter: X: https://qr.diamandis.com/twitter Instagram: https://qr.diamandis.com/instagram Connect with David X: https://x.com/davidasinclair Instagram: https://www.instagram.com/davidsinclairphd/ Website: https://davidasinclair.com/ Listen to MOONSHOTS: Apple: https://qr.diamandis.com/applepodcast Spotify: https://qr.diamandis.com/spotifypodcast – *Recorded on March 9th, 2026 *The views expressed by me and all guests are personal opinions and do not constitute Financial, Medical, or Legal advice.

The $10B Satellite Empire Putting AI in Orbit, Why Chips Beat Rockets & China's #1 Open Model | #266
15.4K views

SpaceX IPOs at $2.89T Market Cap, US Govt Suspends Fable & Mythos 5, Altman Delays OpenAI’s IPO |265
173.3K views

Brian Armstrong on Bitcoin, Anthropic Drops Fable 5 & Mythos 5, NewLimit's $435M Age-Reversal | 264
157.6K views

Emerging Situation: Anthropic's Global Pause, Recursive Self-Improvement, and AI Personhood Arrives
161.3K views

Anthropic Files $965B IPO, Trump Signs AI Executive Order, and ChatGPT Crosses 1B Users | EP #262
137.7K views

Ray Kurzweil on Why We’re Living in the Singularity | EP #261
159.4K views